[Position statement: surgery and diabetes mellitus (Update 2023)].
Positionspapier: Operation und Diabetes mellitus (Update 2023).
Diabetes mellitus
Glycemic control
Insulin therapy
Oral antihyperglycemic therapy
Perioperative management
Journal
Wiener klinische Wochenschrift
ISSN: 1613-7671
Titre abrégé: Wien Klin Wochenschr
Pays: Austria
ID NLM: 21620870R
Informations de publication
Date de publication:
Jan 2023
Jan 2023
Historique:
accepted:
09
11
2022
medline:
28
4
2023
pubmed:
27
4
2023
entrez:
26
4
2023
Statut:
ppublish
Résumé
This position statement reflects the perspective of the Austrian Diabetes Association concerning the perioperative management of people with diabetes mellitus based on the available scientific evidence. The paper covers necessary preoperative examinations from an internal/diabetological point of view as well as the perioperative metabolic control by means of oral antihyperglycemic and/or insulin therapy. Das vorliegende Positionspapier beschreibt die Sicht der Österreichischen Diabetes Gesellschaft hinsichtlich des perioperativen Managements von Menschen mit Diabetes mellitus auf Basis der verfügbaren wissenschaftlichen Evidenz. Dabei wird Bezug genommen auf die präoperative Begutachtung und Vorbereitung sowie auf die perioperative Stoffwechselkontrolle mittels oraler Antidiabetika und/oder injektabler Therapie (Insulin‑/GLP-1-RA-therapie).
Autres résumés
Type: Publisher
(ger)
Das vorliegende Positionspapier beschreibt die Sicht der Österreichischen Diabetes Gesellschaft hinsichtlich des perioperativen Managements von Menschen mit Diabetes mellitus auf Basis der verfügbaren wissenschaftlichen Evidenz. Dabei wird Bezug genommen auf die präoperative Begutachtung und Vorbereitung sowie auf die perioperative Stoffwechselkontrolle mittels oraler Antidiabetika und/oder injektabler Therapie (Insulin‑/GLP-1-RA-therapie).
Identifiants
pubmed: 37101047
doi: 10.1007/s00508-022-02121-z
pii: 10.1007/s00508-022-02121-z
pmc: PMC10133078
doi:
Substances chimiques
Hypoglycemic Agents
0
Insulin
0
Blood Glucose
0
Types de publication
English Abstract
Journal Article
Langues
ger
Sous-ensembles de citation
IM
Pagination
256-271Informations de copyright
© 2023. The Author(s).
Références
Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.
pubmed: 34879977
doi: 10.1016/j.diabres.2021.109119
Jin X, Wang J, Ma Y, Li X, An P, Wang J, et al. Association between perioperative glycemic control strategy and mortality in patients with diabetes undergoing cardiac surgery: a systematic review and meta-analysis. Front Endocrinol. 2020;11:513073.
doi: 10.3389/fendo.2020.513073
Buggy DJ, Nolan R, Coburn M, Columb M, Hermanides J, Hollman MW, et al. Protocol for a prospective, international cohort study on the management and outcomes of perioperative care among European diabetic patients (MOPED). BMJ Open. 2021;11(9):e44394.
pubmed: 34489264
pmcid: 8422310
doi: 10.1136/bmjopen-2020-044394
Österr. Ges. f. Anästhesiologie, Reanimation und Intensivmedizin (ÖGARI). ÖGARI – Quellleitlinie zur präoperativen PatientInnenevaluierung (Juli 2011) inkl. Anamnesebogen. 2011. https://www.oegari.at/arbeitsgruppen/arge-praeoperatives-und-tagesklinisches-patientenmanagement/942 . Zugegriffen: 17. Juni 2022.
Deutsche Diabetes Gesellschaft. S3-Leitlinie Therapie des Typ-1-Diabetes, 2. Auflage. 2018;(2):109.
Wallmeier M. Positionspapier der Deutschen Diabetes Gesellschaft zur Therapie des Diabetes mellitus im Krankenhaus [Internet]. 2016. Verfügbar unter: https://www.ddg.info/fileadmin/user_upload/06_Gesundheitspolitik/01_Stellungnahmen/2018/2018_Positionspapier_der_DDG_zur_Therapie_des_DM_im_Krankenhaus_2._revidierte_Fassung_Dreyer_2017_SV_30052017.pdf . Zugegriffen: 17. Juni 2022.
American Diabetes Association Professional Practice Committee. 16. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2022. Diabetes Care. 16. Dezember 2021;45(Supplement_1):S244–53.
Smilowitz NR, Berger JS. Perioperative cardiovascular risk assessment and management for noncardiac surgery: a review. JAMA. 2020;324(3):279–90.
pubmed: 32692391
doi: 10.1001/jama.2020.7840
Meneghini LF. Perioperative management of diabetes: translating evidence into practice. CCJM. 2009;76(10 suppl 4):S53–S9.
doi: 10.3949/ccjm.76.s4.09
Kadoi Y. Perioperative Considerations in Diabetic Patients. Current Diabetes Reviews. 2010. https://doi.org/10.2174/157339910791658835 .
doi: 10.2174/157339910791658835
pubmed: 20522018
De Hert S, Staender S, Fritsch G, Hinkelbein J, Afshari A, Bettelli G, et al. Pre-operative evaluation of adults undergoing elective noncardiac surgery: Updated guideline from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2018;35(6):407–65.
pubmed: 29708905
doi: 10.1097/EJA.0000000000000817
Holt RIG, DeVries JH, Hess-Fischl A, Hirsch IB, Kirkman MS, Klupa T, et al. The management of type 1 diabetes in adults. A consensus report by the American diabetes association (ADA) and the European association for the study of diabetes (EASD). Diabetes Care. 2021;44(11):2589–625.
pubmed: 34593612
doi: 10.2337/dci21-0043
Akirov A, Grossman A, Shochat T, Shimon I. Mortality among hospitalized patients with hypoglycemia: insulin related and noninsulin related. J Clin Endocrinol Metab. 2017;102(2):416–24.
pubmed: 27854553
doi: 10.1210/jc.2016-2653
Authors/Task Force Members, Kristensen SD, Knuuti J, Saraste A, Anker S, Bøtker HE, et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: the Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J. 2014;35(35):2383–431.
doi: 10.1093/eurheartj/ehu282
Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100(10):1043–9.
pubmed: 10477528
doi: 10.1161/01.CIR.100.10.1043
Inzucchi SE. Management of hyperglycemia in the hospital setting. N Engl J Med. 2006;355(18):1903–11.
pubmed: 17079764
doi: 10.1056/NEJMcp060094
Cheisson G, Jacqueminet S, Cosson E, Ichai C, Leguerrier AM, Nicolescu-Catargi B, et al. Perioperative management of adult diabetic patients. Specific situations. Anaesth Crit Care Pain Med. 2018;37:S31–S55.
pubmed: 29555546
doi: 10.1016/j.accpm.2018.02.022
Reddy P, Duggar B, Butterworth J. Blood glucose management in the patient undergoing cardiac surgery: a review. World J Cardiol. 2014;6(11):1209–17.
pubmed: 25429332
pmcid: 4244617
doi: 10.4330/wjc.v6.i11.1209
Agarwal S, Schechter C, Southern W, Crandall JP, Tomer Y. Preadmission diabetes-specific risk factors for mortality in hospitalized patients with diabetes and Coronavirus disease 2019. Diabetes Care. 2020;43(10):2339–44.
pubmed: 32769128
pmcid: 7510015
doi: 10.2337/dc20-1543
Galway U, Chahar P, Schmidt MT, Araujo-Duran JA, Shivakumar J, Turan A, et al. Perioperative challenges in management of diabetic patients undergoing non-cardiac surgery. World J Diabetes. 2021;12(8):1255–66.
pubmed: 34512891
pmcid: 8394235
doi: 10.4239/wjd.v12.i8.1255
Dogra P, Jialal I. Diabetic perioperative management. In: StatPearls, Hrsg. StatPearls. Treasure Island: StatPearls Publishing; 2022. http://www.ncbi.nlm.nih.gov/books/NBK540965/ .
Frisch A, Chandra P, Smiley D, Peng L, Rizzo M, Gatcliffe C, et al. Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery. Diabetes Care. 2010;33(8):1783–8.
pubmed: 20435798
pmcid: 2909062
doi: 10.2337/dc10-0304
Kotagal M, Symons RG, Hirsch IB, Umpierrez GE, Dellinger EP, Farrokhi ET, et al. Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes. Ann Surg. 2015;261(1):97–103.
pubmed: 25133932
doi: 10.1097/SLA.0000000000000688
Umpierrez G, Cardona S, Pasquel F, Jacobs S, Peng L, Unigwe M, et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary artery bypass graft surgery: GLUCO-CABG trial. Diabetes Care. 2015;38(9):1665–72.
pubmed: 26180108
pmcid: 4542267
doi: 10.2337/dc15-0303
Vervoort D, Lia H, Fremes SE. Sweet victory: optimizing glycemic control after coronary artery bypass grafting. J Card Surg. 2022;37(4):937–40.
pubmed: 35092621
doi: 10.1111/jocs.16278
Malone DL, Genuit T, Tracy JK, Gannon C, Napolitano LM. Surgical site infections: reanalysis of risk factors. J Surg Res. 2002;103(1):89–95.
pubmed: 11855922
doi: 10.1006/jsre.2001.6343
Liu Q, Aggarwal A, Wu M, Darwish OA, Baldino K, Haug V, et al. Impact of diabetes on outcomes in breast reconstruction: a systematic review and meta-analysis. J Plast Reconstr Aesthetic Surg. 2022;75(6):1793–804.
doi: 10.1016/j.bjps.2022.02.053
Dhatariya K, Levy N, Kilvert A, Watson B, Cousins D, Flanagan D, et al. NHS Diabetes guideline for the perioperative management of the adult patient with diabetes. Diabet Med. 2012;29(4):420–33.
pubmed: 22288687
doi: 10.1111/j.1464-5491.2012.03582.x
Pennington Z, Lubelski D, Westbroek EM, Ahmed AK, Passias PG, Sciubba DM. Persistent postoperative hyperglycemia as a risk factor for operative treatment of deep wound infection after spine surgery. Neurosurgery. 2020;87(2):211–9.
pubmed: 31555808
doi: 10.1093/neuros/nyz405
Levy N, Dhatariya K. Pre-operative optimisation of the surgical patient with diagnosed and undiagnosed diabetes: a practical review. Anaesthesia. 2019;74(S1):58–66.
pubmed: 30604420
doi: 10.1111/anae.14510
Bennett SR, Alayesh YM, Algarni AM, et al. Effect of Acute Stress Glycemic Control and Long-Term Glycemic Control on the Incidence of Post-Operative Infection in Diabetics Undergoing Cardiac Surgery. Cureus. 2021;13(3):e14031. https://doi.org/10.7759/cureus.14031 .
doi: 10.7759/cureus.14031
pubmed: 33898119
pmcid: 8059486
Zhang Y, Zheng QJ, Wang S, Zeng SX, Zhang YP, Bai XJ, et al. Diabetes mellitus is associated with increased risk of surgical site infections: a meta-analysis of prospective cohort studies. Am J Infect Control. 2015;43(8):810–5.
pubmed: 26234220
doi: 10.1016/j.ajic.2015.04.003
Martin ET, Kaye KS, Knott C, Nguyen H, Santarossa M, Evans R, et al. Diabetes and risk of surgical site infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2016;37(1):88–99.
pubmed: 26503187
doi: 10.1017/ice.2015.249
Zhang H, Yuan X, Osnabrugge RLJ, Meng D, Gao H, Zhang S, et al. Influence of diabetes mellitus on long-term clinical and economic outcomes after coronary artery bypass grafting. Ann Thorac Surg. 2014;97(6):2073–9.
pubmed: 24751154
doi: 10.1016/j.athoracsur.2014.02.047
Bustamante-Munguira J, Herrera-Gómez F, Ruiz-Álvarez M, Hernández-Aceituno A, Figuerola-Tejerina A. A new surgical site infection risk score: infection risk index in cardiac surgery. J Clin Med. 2019;8(4):480.
pubmed: 30970636
pmcid: 6517895
doi: 10.3390/jcm8040480
Ling ML, Apisarnthanarak A, Abbas A, Morikane K, Lee KY, Warrier A, et al. APSIC guidelines for the prevention of surgical site infections. Antimicrob Resist Infect Control. 2019;8:174.
pubmed: 31749962
pmcid: 6852795
doi: 10.1186/s13756-019-0638-8
Duwayri Y, Jordan WD. Diabetes, dysglycemia, and vascular surgery. J Vasc Surg. 2020;71(2):701–11.
pubmed: 31327619
doi: 10.1016/j.jvs.2019.05.027
Chuang SC, Lee KT, Chang WT, Wang SN, Kuo KK, Chen JS, et al. Risk factors for wound infection after cholecystectomy. J Formos Med Assoc. 2004;103(8):607–12.
pubmed: 15340659
Dougherty SM, Schommer J, Salinas JL, Zilles B, Belding-Schmitt M, Rogers WK, et al. Immediate preoperative hyperglycemia correlates with complications in non-cardiac surgical cases. J Clin Anesth. 2021;74:110375.
pubmed: 34147016
pmcid: 8627687
doi: 10.1016/j.jclinane.2021.110375
Garg R, Schuman B, Bader A, Hurwitz S, Turchin A, Underwood P, et al. Effect of preoperative diabetes management on glycemic control and clinical outcomes after elective surgery. Ann Surg. 2018;267(5):858–62.
pubmed: 28549013
doi: 10.1097/SLA.0000000000002323
Korytkowski MT, Muniyappa R, Antinori-Lent K, Donihi AC, Drincic AT, Hirsch IB, et al. Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2022;107(8):2101–28. https://doi.org/10.1210/clinem/dgac278 .
doi: 10.1210/clinem/dgac278
pubmed: 35690958
Kim HJ, Shim JK, Youn YN, Song JW, Lee H, Kwak YL. Influence of preoperative hemoglobin A1c on early outcomes in patients with diabetes mellitus undergoing off-pump coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2020;159(2):568–76.
pubmed: 30833085
doi: 10.1016/j.jtcvs.2019.01.086
Bhattacharya S, Kalra S, Kapoor N, Singla R, Dutta D, Aggarwal S, et al. Expert opinion on the preoperative medical optimization of adults with diabetes undergoing metabolic surgery. World J Diabetes. 2021;12(10):1587–621.
pubmed: 34754367
pmcid: 8554368
doi: 10.4239/wjd.v12.i10.1587
Godshaw BM, Ojard CA, Adams TM, Chimento GF, Mohammed A, Waddell BS. Preoperative glycemic control predicts perioperative serum glucose levels in patients undergoing total joint arthroplasty. J Arthroplasty. 2018;33(7):S76–S80.
pubmed: 29576485
doi: 10.1016/j.arth.2018.02.071
Jehan F, Khan M, Sakran JV, Khreiss M, O’Keeffe T, Chi A, et al. Perioperative glycemic control and postoperative complications in patients undergoing emergency general surgery: what is the role of Plasma Hemoglobin A1c? J Trauma Acute Care Surg. 2018;84(1):112–7.
pubmed: 29040204
doi: 10.1097/TA.0000000000001724
Underwood P, Askari R, Hurwitz S, Chamarthi B, Garg R. Preoperative A1C and clinical outcomes in patients with diabetes undergoing major noncardiac surgical procedures. Diabetes Care. 2014;37(3):611–6.
pubmed: 24170760
doi: 10.2337/dc13-1929
Wong JKL, Ke Y, Ong YJ, Li H, Wong TH, Abdullah HR. The impact of preoperative glycated hemoglobin (HbA1c) on postoperative complications after elective major abdominal surgery: a meta-analysis. Korean J Anesthesiol. 2022;75(1):47–60.
pubmed: 34619855
doi: 10.4097/kja.21295
van den Boom W, Schroeder RA, Manning MW, Setji TL, Fiestan GO, Dunson DB. Effect of A1C and glucose on postoperative mortality in noncardiac and cardiac surgeries. Diabetes Care. 2018;41(4):782–8.
pubmed: 29440113
doi: 10.2337/dc17-2232
Bardia A, Khabbaz K, Mueller A, Mathur P, Novack V, Talmor D, et al. The association between preoperative hemoglobin A1C and postoperative glycemic variability on 30-day major adverse outcomes following isolated cardiac valvular surgery. Anesth Analg. 2017;124(1):16–22.
pubmed: 27861432
doi: 10.1213/ANE.0000000000001715
Morey-Vargas OL, Aminian A, Steckner K, Zhou K, Kashyap SR, Cetin D, et al. Perioperative management of diabetes in patients undergoing bariatric and metabolic surgery: a narrative review and the Cleveland Clinic practical recommendations. Surg Obes Relat Dis. 2022;18(8):1087–101. https://doi.org/10.1016/j.soard.2022.05.008 .
doi: 10.1016/j.soard.2022.05.008
pubmed: 35752593
Lee A, Haddad D, Rybin D, Howell C, Ghaderi I, Berman S, et al. The impact of hemoglobin A1c on outcomes after lower extremity bypass. J Vasc Surg. 2021;73(4):1332–1339.e5.
pubmed: 32730894
doi: 10.1016/j.jvs.2020.05.036
Samuel N, Mustafa A, Hawkins H, Wei N, Boyle M, De Alwis N, et al. Influence of pre-operative HbA1c on Bariatric surgery outcomes—the Sunderland (UK) experience. Obes Surg. 2022;32(1):42–7.
pubmed: 34632532
doi: 10.1007/s11695-021-05741-y
Turgeon RD, Koshman SL, Youngson E, Pearson GJ. Association between hemoglobin A1c and major adverse coronary events in patients with diabetes following coronary artery bypass surgery. Pharmacotherapy. 2020;40(2):116–24.
pubmed: 31883378
doi: 10.1002/phar.2359
Corazzari C, Matteucci M, Kołodziejczak M, Kowalewski M, Formenti AM, Giustina A, et al. Impact of preoperative glycometabolic status on outcomes in cardiac surgery: Systematic review and meta-analysis. J Thorac Cardiovasc Surg. 2022;164(6):1950–60.e10. https://doi.org/10.1016/j.jtcvs.2021.05.035 .
doi: 10.1016/j.jtcvs.2021.05.035
pubmed: 34176617
Ayman G, Dhatariya K, Dhesi J, Lobo D, Graja A, Grocott M, et al. Guideline for Perioperative Care for People with Diabetes Mellitus Undergoing Elective and Emergency Surgery [Internet]. 2021. Verfügbar unter: https://www.cpoc.org.uk/sites/cpoc/files/documents/2021-03/CPOC-Guideline%20for%20Perioperative%20Care%20for%20People%20with%20Diabetes%20Mellitus%20Undergoing%20Elective%20and%20Emergency%20Surgery.pdf . Zugegriffen: 26. Juni 2022.
Vongsumran N, Buranapin S, Manosroi W. Standardized glycemic management versus conventional glycemic management and postoperative outcomes in type 2 diabetes patients undergoing elective surgery. Diabetes Metab Syndr Obes. 2020;13:2593–601.
pubmed: 32801810
pmcid: 7383109
doi: 10.2147/DMSO.S262444
Rupprecht B, Stöckl A, Stöckl S, Dietrich C. Therapie des Diabetes mellitus in der perioperativen Medizin – ein Update. Anaesthesist. 2021;70(6):451–65.
pubmed: 33141238
doi: 10.1007/s00101-020-00875-7
Qi QYD, Kyi M, Pemberton E, Colman PG, Fourlanos S. The pro-diab Melbourne perioperative study: a structured pre-admission perioperative diabetes management plan to improve medication usage in elective surgery. Diabet Med. 2022;39(7):e14838.
pubmed: 35357734
pmcid: 9325050
doi: 10.1111/dme.14838
Mader JK, Brix J, Aberer F, Vonbank A, Resl M, Pieber TR, et al. Diabetesmanagement im Krankenhaus (Update 2019). Wien Klin Wochenschr. 2019;131(1):200–11.
pubmed: 30980162
doi: 10.1007/s00508-019-1447-z
Klonoff DC, Buckingham B, Christiansen JS, Montori VM, Tamborlane WV, Vigersky RA, et al. Continuous glucose monitoring: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(10):2968–79.
pubmed: 21976745
doi: 10.1210/jc.2010-2756
Umpierrez GE, Klonoff DC. Diabetes technology update: use of insulin pumps and continuous glucose monitoring in the hospital. Diabetes Care. 2018;41(8):1579–89.
pubmed: 29936424
pmcid: 6054505
doi: 10.2337/dci18-0002
Kosiborod M, Gottlieb RK, Sekella JA, Peterman D, Grodzinsky A, Kennedy P, et al. Performance of the Medtronic Sentrino continuous glucose management (CGM) system in the cardiac intensive care unit. Bmj Open Diabetes Res Care. 2014;2(1):e37.
pubmed: 25452874
pmcid: 4212554
doi: 10.1136/bmjdrc-2014-000037
Davis GM, Spanakis EK, Migdal AL, Singh LG, Albury B, Urrutia MA, et al. Accuracy of Dexcom G6 continuous glucose monitoring in non–critically ill hospitalized patients with diabetes. Diabetes Care. 2021;44(7):1641–6.
pubmed: 34099515
pmcid: 8323182
doi: 10.2337/dc20-2856
Sweeney AT, Pena S, Sandeep J, Hernandez B, Chen Y, Breeze JL, et al. Use of a continuous glucose monitoring system in high-risk hospitalized noncritically ill patients with diabetes after cardiac surgery and during their transition of care from the intensive care unit during COVID-19: a pilot study. Endocr Pract. 2022;28(6):615–21.
pubmed: 35276324
pmcid: 8902897
doi: 10.1016/j.eprac.2022.03.001
Siegelaar SE, Barwari T, Hermanides J, van der Voort PHJ, Hoekstra JBL, DeVries JH. Microcirculation and its relation to continuous subcutaneous glucose sensor accuracy in cardiac surgery patients in the intensive care unit. J Thorac Cardiovasc Surg. 2013;146(5):1283–9.
pubmed: 23879929
doi: 10.1016/j.jtcvs.2013.06.017
Schierenbeck F, Franco-Cereceda A, Liska J. Accuracy of 2 different continuous glucose monitoring systems in patients undergoing cardiac surgery. J Diabetes Sci Technol. 2016;11(1):108–16.
pubmed: 27257168
pmcid: 5375060
doi: 10.1177/1932296816651632
Carlsson CJ, Nørgaard K, Oxbøll AB, Søgaard MIV, Achiam MP, Jørgensen LN, et al. Continuous glucose monitoring reveals perioperative hypoglycemia in most patients with diabetes undergoing major surgery: a prospective cohort study. Annals of surgery.. http://journals.lww.com/annalsofsurgery/Abstract/9000/Continuous_Glucose_Monitoring_Reveals.93241.aspx (Erstellt: 10. März 2022). Zugegriffen: 14. Juni 2022.
Palermo NE, Garg R. Perioperative management of diabetes mellitus: novel approaches. Curr Diab Rep. 2019;19(4):14.
pubmed: 30806818
doi: 10.1007/s11892-019-1132-7
Ruzycki SM, Harrison T, Cameron A, Helmle K, McKeen J. Perioperative Glycemic management for patients with and without diabetes: a review for internists. Can J Gen Intern Med. 2021;16(1):17–23.
doi: 10.22374/cjgim.v16i1.435
Arrighi-Allisan AE, Neifert SN, Gal JS, Zeldin L, Zimering JH, Gilligan JT, et al. Diabetes is predictive of postoperative outcomes and readmission following posterior lumbar fusion. Global Spine J. 2022;12(2):229–36.
pubmed: 35253463
doi: 10.1177/2192568220948480
Bommer C, Heesemann E, Sagalova V, Manne-Goehler J, Atun R, Bärnighausen T, et al. The global economic burden of diabetes in adults aged 20–79 years: a cost-of-illness study. Lancet Diabetes Endocrinol. 2017;5(6):423–30.
pubmed: 28456416
doi: 10.1016/S2213-8587(17)30097-9
Jacober SJ, Sowers JR. An update on perioperative management of diabetes. Arch Intern Med. 1999;159(20):2405–11.
pubmed: 10665888
doi: 10.1001/archinte.159.20.2405
Nair BG, Neradilek MB, Newman SF, Horibe M. Association between acute phase perioperative glucose parameters and postoperative outcomes in diabetic and non-diabetic patients undergoing non-cardiac surgery. Am J Surg. 2019;218(2):302–10.
pubmed: 30343876
doi: 10.1016/j.amjsurg.2018.10.024
S3-Leitlinie Therapie des Typ-1-Diabetes, 2. Auflage. 2018;109.
Malcolm J, Halperin I, Miller DB, Moore S, Nerenberg KA, Woo V, et al. In-hospital management of diabetes. Can J Diabetes. 2018;42:S115–S23.
pubmed: 29650083
doi: 10.1016/j.jcjd.2017.10.014
Australian Diabetes Society. Peri-operative diabetes management guidelines. 2012.
Griesdale DEG, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ. 2009;180(8):821–7.
pubmed: 19318387
doi: 10.1503/cmaj.090206
Clodi M, Resl M, Abrahamian H, Föger B, Weitgasser R. Therapie der Hyperglykämie bei erwachsenen, kritisch kranken PatientInnen (Update 2019). Wien Klin Wochenschr. 2019;131(1):218–20.
pubmed: 30980173
doi: 10.1007/s00508-019-1486-5
Jauch KW. Hunger und Postaggressions‑/ Stressstoffwechsel. In: Stein J, Jauch KW, Hrsg. Praxishandbuch klinische Ernährung und Infusionstherapie. Berlin, Heidelberg: Springer; 2003. S. 214–29. https://doi.org/10.1007/978-3-642-55896-2_13 .
doi: 10.1007/978-3-642-55896-2_13
Hermanides J, Qeva E, Preckel B, Bilotta F. Perioperative hyperglycemia and neurocognitive outcome after surgery: a systematic review. Minerva Anestesiol. 2018;84(10):1178–88.
pubmed: 29589415
doi: 10.23736/S0375-9393.18.12400-X
Greco G, Ferket BS, D’Alessandro DA, Shi W, Horvath KA, Rosen A, et al. Diabetes and the association of postoperative hyperglycemia with clinical and economic outcomes in cardiac surgery. Diabetes Care. 2016;39(3):408–17.
pubmed: 26786574
pmcid: 4764032
doi: 10.2337/dc15-1817
Buchleitner AM, Martínez-Alonso M, Hernández M, Solà I, Mauricio D. Perioperative glycaemic control for diabetic patients undergoing surgery. Cochrane Database Syst Rev. 2012; https://doi.org/10.1002/14651858.CD007315.pub2/full .
doi: 10.1002/14651858.CD007315.pub2/full
pubmed: 22972106
Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359–67.
pubmed: 11794168
doi: 10.1056/NEJMoa011300
The NICE-SUGAR Study Investigators for the Australian and New Zealand Intensive Care Society Clinical Trials Group and the Canadian Critical Care Trials Group. Intensive versus Conventional Glucose Control in Critically Ill Patients. N Engl J Med. 2009;360(13):1283–97.
doi: 10.1056/NEJMoa0810625
Lai J, Li Q, He Y, Zou S, Bai X, Rastogi S. Glycemic control regimens in the prevention of surgical site infections: a meta-analysis of randomized clinical trials. Front Surg. 2022;9:855409.
pubmed: 35402490
pmcid: 8990940
doi: 10.3389/fsurg.2022.855409
Lake A, Arthur A, Byrne C, Davenport K, Yamamoto JM, Murphy HR. The effect of hypoglycaemia during hospital admission on health-related outcomes for people with diabetes: a systematic review and meta-analysis. Diabet Med. 2019;36(11):1349–59.
pubmed: 31441089
pmcid: 7004204
doi: 10.1111/dme.14115
Devanesan A, Lloyd J, Samad H, Saha S. Glycaemic control in intensive care: everything in moderation. J Intensive Care Soc. 2016;17(4):280–3.
pubmed: 28979511
pmcid: 5624481
doi: 10.1177/1751143716644455
Haga KK, McClymont KL, Clarke S, Grounds RS, Ng KYB, Glyde DW, et al. The effect of tight glycaemic control, during and after cardiac surgery, on patient mortality and morbidity: a systematic review and meta-analysis. J Cardiothorac Surg. 2011;6:3.
pubmed: 21219624
pmcid: 3023693
doi: 10.1186/1749-8090-6-3
Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland diabetic project. Endocr Pract. 2004;10:21–33.
pubmed: 15251637
doi: 10.4158/EP.10.S2.21
Yong PH, Weinberg L, Torkamani N, Churilov L, Robbins RJ, Ma R, et al. The presence of diabetes and higher HbA1c are independently associated with adverse outcomes after surgery. Diabetes Care. 2018;41(6):1172–9.
pubmed: 29581095
doi: 10.2337/dc17-2304
Newman JD, Wilcox T, Smilowitz NR, Berger JS. Influence of diabetes on trends in perioperative cardiovascular events. Diabetes Care. 2018;41(6):1268–74.
pubmed: 29618572
pmcid: 5961401
doi: 10.2337/dc17-2046
Critchley JA, Carey IM, Harris T, DeWilde S, Hosking FJ, Cook DG. Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study. Diabetes Care. 2018;41(10):2127–35.
pubmed: 30104296
doi: 10.2337/dc18-0287
Magee F, Bailey M, Pilcher DV, Mårtensson J, Bellomo R. Early glycemia and mortality in critically ill septic patients: Interaction with insulin-treated diabetes. J Crit Care. 2018;45:170–7.
pubmed: 29544173
doi: 10.1016/j.jcrc.2018.03.012
Davis G, Fayfman M, Reyes-Umpierrez D, Hafeez S, Pasquel FJ, Vellanki P, et al. Stress hyperglycemia in general surgery: why should we care? J Diabetes Complications. 2018;32(3):305–9.
pubmed: 29273446
doi: 10.1016/j.jdiacomp.2017.11.010
Kurisu K, Tsurutani Y, Inoue K, Hoshino Y, Saiki F, Yoshiuchi K. Intra-individual association between C‑reactive protein and insulin administration in postoperative lumbar spinal canal stenosis patients: a retrospective cohort study. J Diabetes Investig. 2020;11(4):980–4.
pubmed: 31912618
pmcid: 7378432
doi: 10.1111/jdi.13210
Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet. 2009;373(9677):1798–807.
pubmed: 19465235
pmcid: 3144755
doi: 10.1016/S0140-6736(09)60553-5
Metformin. https://www.basg.gv.at/metformin . Zugegriffen: 27. Juni 2022.
Biguanides and lactic acidosis in diabetics. Br Med J. 1977;2(6100):1436. https://doi.org/10.1136/bmj.2.6100.1436 .
Lalau JD, Kajbaf F, Protti A, Christensen MM, Broe MED, Wiernsperger N. Metformin-associated lactic acidosis (MALA): moving towards a new paradigm. Diabetes Obes Metab. 2017;19(11):1502–12.
pubmed: 28417525
doi: 10.1111/dom.12974
DeFronzo R, Fleming GA, Chen K, Bicsak TA. Metformin-associated lactic acidosis: current perspectives on causes and risk. Metabolism. 2016;65(2):20–9.
pubmed: 26773926
doi: 10.1016/j.metabol.2015.10.014
Gasanova I, Meng J, Minhajuddin A, Melikman E, Alexander JC, Joshi GP. Preoperative continuation versus interruption of oral hypoglycemics in type 2 diabetic patients undergoing ambulatory surgery: a randomized controlled trial. Anesth Analg. 2018;127(4):e54.
pubmed: 30044293
doi: 10.1213/ANE.0000000000003675
Hulst AH, Polderman JAW, Ouweneel E, Pijl AJ, Hollmann MW, DeVries JH, et al. Peri-operative continuation of metformin does not improve glycaemic control in patients with type 2 diabetes: A randomized controlled trial. Diabetes Obes Metab. 2018;20(3):749–52.
pubmed: 28940961
doi: 10.1111/dom.13118
Pontes JPJ, Mendes FF, Vasconcelos MM, Batista NR. Evaluation and perioperative management of patients with diabetes mellitus. A challenge for the anesthesiologist. Braz J Anesthesiol. 2018;68(1):75–86.
pubmed: 28571661
doi: 10.1016/j.bjan.2017.04.017
Hulst AH, Plummer MP, Hollmann MW, DeVries JH, Preckel B, Deane AM, et al. Systematic review of incretin therapy during peri-operative and intensive care. Crit Care. 2018;22(1):299.
pubmed: 30428906
pmcid: 6236901
doi: 10.1186/s13054-018-2197-4
Macdonald JJ, Neupane S, Gianchandani RY. The potential role of incretin therapy in the hospital setting. Clin Diabetes Endocrinol. 2015;1:4.
pubmed: 28702223
pmcid: 5469200
doi: 10.1186/s40842-015-0005-5
Vellanki P, Rasouli N, Baldwin D, Alexanian S, Anzola I, Urrutia M, et al. Glycaemic efficacy and safety of Linagliptin compared to basal-bolus insulin regimen in patients with type 2 diabetes undergoing non-cardiac surgery: a multicenter randomized clinical trial. Diabetes Obes Metab. 2019;21(4):837–43.
pubmed: 30456796
doi: 10.1111/dom.13587
Fayfman M, Davis G, Duggan E, Urrutia M, Chachkhiani D, Schindler J, et al. Sitagliptin for prevention of stress hyperglycemia in patients without diabetes undergoing general surgery: a pilot randomized study. J Diabetes Complications. 2018;32(12):1091–6.
pubmed: 30253968
pmcid: 6668912
doi: 10.1016/j.jdiacomp.2018.08.014
Cardona S, Tsegka K, Pasquel FJ, Jacobs S, Halkos M, Keeling WB, et al. Sitagliptin for the prevention and treatment of perioperative hyperglycaemia in patients with type 2 diabetes undergoing cardiac surgery: a randomized controlled trial. Diabetes Obes Metab. 2021;23(2):480–8.
pubmed: 33140566
doi: 10.1111/dom.14241
Pasquel FJ, Gianchandani R, Rubin DJ, Dungan KM, Anzola I, Gomez PC, et al. Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial. Lancet Diabetes Endocrinol. 2017;5(2):125–33.
pubmed: 27964837
doi: 10.1016/S2213-8587(16)30402-8
Preiser JC, Provenzano B, Mongkolpun W, Halenarova K, Cnop M. Perioperative management of oral glucose-lowering drugs in the patient with type 2 diabetes. Anesthesiology. 2020;133(2):430–8.
pubmed: 32667156
doi: 10.1097/ALN.0000000000003237
Hulst AH, Visscher MJ, Godfried MB, Thiel B, Gerritse BM, Scohy TV, et al. Liraglutide for perioperative management of hyperglycaemia in cardiac surgery patients: a multicentre randomized superiority trial. Diabetes Obes Metab. 2020;22(4):557–65.
pubmed: 31749275
doi: 10.1111/dom.13927
Makino H, Tanaka A, Asakura K, Koezuka R, Tochiya M, Ohata Y, et al. Addition of low-dose liraglutide to insulin therapy is useful for glycaemic control during the peri-operative period: effect of glucagon-like peptide‑1 receptor agonist therapy on glycaemic control in patients undergoing cardiac surgery (GLOLIA study). Diabet Med. 2019;36(12):1621–8.
pubmed: 31335979
doi: 10.1111/dme.14084
Polderman JAW, van Steen SCJ, Thiel B, Godfried MB, Houweling PL, Hollmann MW, et al. Peri-operative management of patients with type‑2 diabetes mellitus undergoing non-cardiac surgery using liraglutide, glucose–insulin–potassium infusion or intravenous insulin bolus regimens: a randomised controlled trial. Anaesthesia. 2018;73(3):332–9.
pubmed: 29230803
doi: 10.1111/anae.14180
Polderman JA, Houweling PL, Hollmann MW, DeVries JH, Preckel B, Hermanides J. Study protocol of a randomised controlled trial comparing perioperative intravenous insulin, GIK or GLP‑1 treatment in diabetes–PILGRIM trial. BMC Anesthesiol. 2014;14(1):91.
pubmed: 25419179
pmcid: 4240889
doi: 10.1186/1471-2253-14-91
Wolf P, Fellinger P, Pfleger L, Beiglböck H, Krumpolec P, Barbieri C, et al. Gluconeogenesis, but not glycogenolysis, contributes to the increase in endogenous glucose production by SGLT‑2 inhibition. Diabetes Care. 2021;44(2):541–8.
pubmed: 33318126
doi: 10.2337/dc20-1983
Menghoum N, Oriot P, Hermans MP. Clinical and biochemical characteristics and analysis of risk factors for euglycaemic diabetic ketoacidosis in type 2 diabetic individuals treated with SGLT2 inhibitors: A review of 72 cases over a 4.5-year period. Diabetes Metab Syndr Clin Res Rev. 2021;15(6):102275.
doi: 10.1016/j.dsx.2021.102275
Bonora BM, Avogaro A, Fadini GP. Sodium-glucose co-transporter‑2 inhibitors and diabetic ketoacidosis: an updated review of the literature. Diabetes Obes Metab. 2018;20(1):25–33.
pubmed: 28517913
doi: 10.1111/dom.13012
Kietaibl AT, Fasching P, Glaser K, Petter-Puchner AH. Acute abdomen as a side-effect of sodium–glucose co-transporter 2 inhibitors in diabetic patients. Br J Surg. 2021;108(12):e409. https://doi.org/10.1093/bjs/znab390 .
doi: 10.1093/bjs/znab390
pubmed: 34791086
Milder DA, Milder TY, Kam PCA. Sodium-glucose co-transporter type‑2 inhibitors: pharmacology and peri-operative considerations. Anaesthesia. 2018;73(8):1008–18.
pubmed: 29529345
doi: 10.1111/anae.14251
Bamgboye AO, Oni IO, Collier A. Predisposing factors for the development of diabetic ketoacidosis with lower than anticipated glucose levels in type 2 diabetes patients on SGLT2-inhibitors: a review. Eur J Clin Pharmacol. 2021;77(5):651–7.
pubmed: 33244632
doi: 10.1007/s00228-020-03051-3
Thiruvenkatarajan V, Meyer EJ, Nanjappa N, Van Wijk RM, Jesudason D. Perioperative diabetic ketoacidosis associated with sodium-glucose co-transporter‑2 inhibitors: a systematic review. Br J Anaesth. 2019;123(1):27–36.
pubmed: 31060732
doi: 10.1016/j.bja.2019.03.028
Kietaibl AT, Fasching P, Glaser K, Petter-Puchner AH. New diabetic medication sodium-glucose cotransporter‑2 inhibitors can induce euglycemic ketoacidosis and mimic surgical diseases: a case report and review of literature. Front Surg. 2022;9:828649.
pubmed: 35402477
pmcid: 8987984
doi: 10.3389/fsurg.2022.828649
Pontes JPJ, de Melo CS, Arantes FBB, de Souza Ramos JTG, Módolo NSP, Navarro E Lima LH. Perioperative euglycemic diabetic ketoacidosis following use of SGLT‑2 inhibitors after cardiac surgery. J Clin Anesth. 2021;71:110201.
pubmed: 33647525
doi: 10.1016/j.jclinane.2021.110201
Long B, Lentz S, Koyfman A, Gottlieb M. Euglycemic diabetic ketoacidosis: etiologies, evaluation, and management. Am J Emerg Med. 2021;44:157–60.
pubmed: 33626481
doi: 10.1016/j.ajem.2021.02.015
Lau A, Bruce S, Wang E, Ree R, Rondi K, Chau A. Perioperative implications of sodium-glucose cotransporter‑2 inhibitors: a case series of euglycemic diabetic ketoacidosis in three patients after cardiac surgery. J Can Anesth. 2018;65(2):188–93.
doi: 10.1007/s12630-017-1018-6
Palmer SC, Tendal B, Mustafa RA, Vandvik PO, Li S, Hao Q, et al. Sodium-glucose cotransporter protein‑2 (SGLT-2) inhibitors and glucagon-like peptide‑1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials. BMJ. 2021;372:m4573.
pubmed: 33441402
pmcid: 7804890
doi: 10.1136/bmj.m4573
Burke KR, Schumacher CA, Harpe SE, SGLT2 Inhibitors. A systematic review of diabetic ketoacidosis and related risk factors in the primary literature. Pharmacotherapy. 2017;37(2):187–94.
pubmed: 27931088
doi: 10.1002/phar.1881
Seki H, Kuratani N, Shiga T, Iwasaki Y, Karita K, Yasuda K, et al. Multicentre prospective observational study of sodium-glucose cotransporter‑2 inhibitor-associated postoperative ketoacidosis: the SAPKA study protocol. Bmj Open. 2021;11(11):e49592.
pubmed: 34815277
pmcid: 8611445
doi: 10.1136/bmjopen-2021-049592
Somagutta MR, Agadi K, Hange N, Jain MS, Batti E, Emuze BO, et al. Euglycemic diabetic ketoacidosis and sodium-glucose cotransporter‑2 inhibitors: a focused review of pathophysiology, risk factors, and triggers. Cureus. 13(3).. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012260/ . Zugegriffen: 19. Apr. 2021.
DeCou JA, Sams SH. New diabetes medications raise new perioperative concerns for the anesthesiologist. Anesth Analg. 2018;126(2):390–2.
pubmed: 29346204
doi: 10.1213/ANE.0000000000002740
Khan NA, Ghali WA, Cagliero E. Perioperative management of blood glucose in adults with diabetes mellitus. 2021. https://www.uptodate.com/contents/perioperative-management-of-blood-glucose-in-adults-with-diabetes-mellitus/print . Zugegriffen: 13. Juni 2022.
Handelsman Y, Henry RR, Bloomgarden ZT, Dagogo-Jack S, DeFronzo RA, Einhorn D, et al. American association of clinical endocrinologists and American college of endocrinology position statement on the association of SGLT‑2 inhibitors and diabetic ketoacidosis. Endocr Pract. 2016;22(6):753–62.
pubmed: 27082665
doi: 10.4158/EP161292.PS
Australian Diabetes Society. Severe euglycaemic ketoacidosis with SGLT2 inhibitor use in the perioperative period. 2018. https://diabetessociety.com.au/documents/2018_ALERT-ADS_SGLT2i_PerioperativeKetoacidosis_v3__final2018_02_14.pdf . Zugegriffen: 8. Juni 2021.
Traill DR. Severe euglycaemic ketoacidosis with SGLT2 inhibitor use in the perioperative period.. http://www.anzca.edu.au/documents/alert-dka-and-oral-hypoglycaemics-20180215.pdf . Zugegriffen: 8. Juni 2021.
Peters AL, Buschur EO, Buse JB, Cohan P, Diner JC, Hirsch IB. Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium–glucose cotransporter 2 inhibition. Diabetes Care. 2015;38(9):1687–93.
pubmed: 26078479
pmcid: 4542270
doi: 10.2337/dc15-0843
Peacock SC, Lovshin JA, Cherney DZI. Perioperative considerations for the use of sodium-glucose cotransporter‑2 inhibitors in patients with type 2 diabetes. Anesth Analg. 2018;126(2):699–704.
pubmed: 28786838
doi: 10.1213/ANE.0000000000002377
FDA. Research C for DE and. FDA revises labels of SGLT2 inhibitors for diabetes to include warnings about too much acid in the blood and serious urinary tract infections. 2021. https://www.fda.gov/drugs/drug-safety-and-availability/fda-revises-labels-sglt2-inhibitors-diabetes-include-warnings-about-too-much-acid-blood-and-serious . Zugegriffen: 5. Juni 2021.
Himes CP, Ganesh R, Wight EC, Simha V, Liebow M. Perioperative evaluation and management of endocrine disorders. Mayo Clin Proc. 2020;95(12):2760–74.
pubmed: 33168157
doi: 10.1016/j.mayocp.2020.05.004
Miura H, Wachtel RE, Loberiza FR, Saito T, Miura M, Nicolosi AC, et al. Diabetes mellitus impairs vasodilation to hypoxia in human coronary arterioles. Circ Res. 2003;92(2):151–8.
pubmed: 12574142
doi: 10.1161/01.RES.0000052671.53256.49
Kuzulugil D, Papeix G, Luu J, Kerridge RK. Recent advances in diabetes treatments and their perioperative implications. Curr Opin Anesthesiol. 2019;32(3):398–404.
doi: 10.1097/ACO.0000000000000735
Neubauer KM, Schaupp L, Plank J, Augustin T, Mautner SI, Tschapeller B, et al. Failure to control hyperglycemia in noncritically ill diabetes patients despite standard glycemic management in a hospital setting. J Diabetes Sci Technol. 2013;7(2):402–9.
pubmed: 23566999
pmcid: 3737642
doi: 10.1177/193229681300700217
Umpierrez GE, Smiley D, Jacobs S, Peng L, Temponi A, Mulligan P, et al. Randomized study of Basal-Bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care. 2011;34(2):256–61.
pubmed: 21228246
pmcid: 3024330
doi: 10.2337/dc10-1407
Umpierrez GE, Smiley D, Hermayer K, Khan A, Olson DE, Newton C, et al. Randomized study comparing a basal-bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care. 2013;36(8):2169–74.
pubmed: 23435159
pmcid: 3714500
doi: 10.2337/dc12-1988
Gandhi GY, Nuttall GA, Abel MD, Mullany CJ, Schaff HV, O’Brien PC, et al. Intensive Intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Ann Intern Med. 2007;146(4):233–43.
pubmed: 17310047
doi: 10.7326/0003-4819-146-4-200702200-00002
Smith I, Kranke P, Murat I, Smith A, O’Sullivan G, Søreide E, et al. Perioperative fasting in adults and children: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2011;28(8):556–69.
pubmed: 21712716
doi: 10.1097/EJA.0b013e3283495ba1
Demma LJ, Carlson KT, Duggan EW, Morrow JG, Umpierrez G. Effect of basal insulin dosage on blood glucose concentration in ambulatory surgery patients with type 2 diabetes. J Clin Anesth. 2017;36:184–8.
pubmed: 28183563
doi: 10.1016/j.jclinane.2016.10.003
Diätologen: Neuerscheinung - neue Kohlenhydrattabelle.. https://www.diaetologen.at/news-detailansicht/artikel/neuerscheinung-neue-kohlenhydrattabelle/ . Zugegriffen: 19. Juni 2022.
Mendez CE, Umpierrez GE. Management of type 1 diabetes in the hospital setting. Curr Diab Rep. 2017;17(10):98.
pubmed: 28913745
doi: 10.1007/s11892-017-0919-7
Nassar AA, Boyle ME, Seifert KM, Beer KA, Apsey HA, Schlinkert RT, et al. Insulin pump therapy in patients with diabetes undergoing surgery. Endocr Pract. 2012;18(1):49–55.
pubmed: 21803711
doi: 10.4158/EP11157.OR
Partridge H, Perkins B, Mathieu S, Nicholls A, Adeniji K. Clinical recommendations in the management of the patient with type 1 diabetes on insulin pump therapy in the perioperative period: a primer for the anaesthetist. Br J Anaesth. 2016;116(1):18–26.
pubmed: 26675948
doi: 10.1093/bja/aev347
Mou Y, Ma D, Zhang J, Tao J, He W, Li W, et al. Continuous subcutaneous insulin infusion reduces the risk of postoperative infection. J Diabetes. 2020;12(5):396–405.
pubmed: 31697444
doi: 10.1111/1753-0407.13008
Kietaibl AT, Kietaibl S. Anästhesiologische Perspektive zum perioperativen Management bei kontinuierlicher subkutaner Insulininfusion (CSII): Stoppen oder fortführen? Wien Med Wochenschr. 2020;170(7):155–67.
pubmed: 31654155
doi: 10.1007/s10354-019-00711-7
Bally L, Thabit H, Hartnell S, Andereggen E, Ruan Y, Wilinska ME, et al. Closed-loop insulin delivery for Glycemic control in noncritical care. N Engl J Med. 2018;379(6):547–56.
pubmed: 29940126
doi: 10.1056/NEJMoa1805233
Boughton CK, Tripyla A, Hartnell S, Daly A, Herzig D, Wilinska ME, et al. Fully automated closed-loop glucose control compared with standard insulin therapy in adults with type 2 diabetes requiring dialysis: an open-label, randomized crossover trial. Nat Med. 2021;27(8):1471–6. https://doi.org/10.1038/s41591-021-01453-z .
doi: 10.1038/s41591-021-01453-z
pubmed: 34349267
pmcid: 8363503
Hanazaki K, Tanioka N, Munekage M, Uemura S, Maeda H. Closed-loop artificial endocrine pancreas from Japan. Artif Organs. 2021;45(9):958–67.
pubmed: 34105784
doi: 10.1111/aor.14008
Shin U, Naoko H, Michinori T, Yuya K, Yuka S, Yuki N, et al. Utility of bedside artificial pancreas for postoperative glycemic control in cardiac surgery. J Artif Organs. 2021;24(2):225–33.
pubmed: 33155103
doi: 10.1007/s10047-020-01223-7
Yoshimoto T, Ikemoto T, Morine Y, Imura S, Saito Y, Yamada S, et al. Impact of using a perioperative artificial endocrine pancreas in pancreatic resection. Ann Gastroenterol Surg. 2020;4(5):591–6.
pubmed: 33005854
pmcid: 7511569
doi: 10.1002/ags3.12374
Akabori H, Tani M, Kitamura N, Maehira H, Imashuku Y, Tsujita Y, et al. Perioperative tight glycemic control using artificial pancreas decreases infectious complications via suppression of inflammatory cytokines in patients who underwent pancreaticoduodenectomy: A prospective, non-randomized clinical trial. Am J Surg. 2020;220(2):365–71.
pubmed: 31836178
doi: 10.1016/j.amjsurg.2019.12.008
Kaddoum R, Khalili A, Shebbo FM, Ghanem N, Daher LA, Ali AB, et al. Automated versus conventional perioperative glycemic control in adult diabetic patients undergoing open heart surgery. BMC Anesthesiol. 2022;22:184.
pubmed: 35710339
pmcid: 9202201
doi: 10.1186/s12871-022-01721-6
Friedell ML, Van Way CW III, Freyberg RW, Almenoff PL. β‑Blockade and Operative Mortality in Noncardiac Surgery: Harmful or Helpful? JAMA Surg. 2015;150(7):658–63.
pubmed: 26017188
doi: 10.1001/jamasurg.2015.86
Barakat AF, Saad M, Abuzaid A, Mentias A, Mahmoud A, Elgendy IY. Perioperative Statin therapy for patients undergoing coronary artery bypass grafting. Ann Thorac Surg. 2016;101(2):818–25.
pubmed: 26794880
doi: 10.1016/j.athoracsur.2015.09.070
POISE Study Group, Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008;371(9627):1839–47. https://doi.org/10.1016/S0140-6736(08)60601-7 .
doi: 10.1016/S0140-6736
Juul AB, Wetterslev J, Gluud C, Kofoed-Enevoldsen A, Jensen G, Callesen T, et al. Effect of perioperative β blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial. BMJ. 2006;332(7556):1482.
pubmed: 16793810
pmcid: 1482337
doi: 10.1136/bmj.332.7556.1482
Putzu A, de Carvalho e Silva CMPD, de Almeida JP, Belletti A, Cassina T, Landoni G, et al. Perioperative statin therapy in cardiac and non-cardiac surgery: a systematic review and meta-analysis of randomized controlled trials. Ann Intensive Care. 2018;8:95.
pubmed: 30264290
pmcid: 6160380
doi: 10.1186/s13613-018-0441-3
Diabetes Canada Clinical Practice Guidelines Expert Committee. Sick-Day Medication List. Canadian Journal of Diabetes. 2018;42:S316.
doi: 10.1016/j.jcjd.2017.10.045
Bischoff M. Perioperativer Umgang mit Begleitmedikation. In: Bischoff M, Graf BM, Redel A, Hrsg. Perioperativer Umgang mit Begleitmedikation. 2019. S. 560–71.